β-Adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography

Pharmacogenomics Journal

Volumn 8, Issue 6, 2008, Pages 408-415

  Aquilante, C L ^a   Yarandi, H N ^a   Cavallari, L H ^a   Andrisin, T E ^a   Terra, S G ^a   Lewis, J F ^b   Hamilton, K K ^b   Johnson, J A ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; ATROPINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOBUTAMINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; SERINE;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEART HEMODYNAMICS; HEART RATE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; COHORT STUDIES; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; GENOTYPE; HEART RATE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA;

EID: 56349093408     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500490     Document Type: Article

References (24)

1. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem 1999; 274: 12670-12674.
2. Rathz DA, Brown KM, Kramer LA, Liggett SB. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002; 39: 155-160.
3. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9419.
4. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74: 44-52.
5. Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G et al. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 2003; 74: 372-379.
6. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA et al. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade. Clin Pharmacol Ther 2003; 73: 366-371.
7. Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS, Wagoner LE, Schwartz A et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003; 9: 1300-1305.
8. Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF et al Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy. Pharmacogenet Genomics 2005; 15: 227-234.
9. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000; 139: 537-542.
10. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B et al. Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33: 1425-1430.
11. La Rosee K, Huntgeburth M, Rosenkranz S, Bohm M, Schnabel P. The Arg389Gly beta1-adrenoceptor gene polymorphism determines contractile response to catecholamines. Pharmacogenetics 2004; 14: 711-716.
12. Usher Jr BW, O'Brien TX. Recent advances in dobutamine stress echocardiography. Clin Cardiol 2000; 23: 560-570.
13. Rodgers GP, Ayanian JZ, Balady G, Beasley JW, Brown KA, Gervino EV et al. American college of cardiology/American heart association clinical competence statement on stress testing: A report of the American college of cardiology/American heart association/American college of physicians - American society of internal medicine task force on clinical competence. J Am Coll Cardiol 2000; 36: 1441-1453.
14. Daly AL, Linares OA, Smith MJ, Starling MR, Supiano MA. Dobutamine pharmacokinetics during dobutamine stress echocardiography. Am J Cardiol 1997; 79: 1381-1386.
15. Lee CY, Pellikka PA, Shub C, Sinak LJ, Seward JB. Hypertensive response during dobutamine stress echocardiography. Am J Cardiol 1997; 80: 970-971.
16. Aquilante CL, Humma LM, Yarandi HN, Andrisin TE, Lewis JF, Hamilton KK et al. Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography. Am J Cardiol 2004; 94: 535-538.
17. Dhond MR, Whitley TB, Singh S, Nguyen TT, Bommer WJ. Incidence and significance of profound hypotension during dobutamine stress echocardiography. Clin Cardiol 2000; 23: 47-50.
18. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH et al. Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999; 9: 511-516.
19. Buscher R, Belger H, Eilmes KJ, Tellkamp R, Radke J, Dhein S et al. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001; 11: 199-205.
20. Ranade K, Jorgenson E, Sheu WH, Pei D, Hsiung CA, Chiang FT et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935-942.
21. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ. The gain-of-function variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond) 2000; 99: 233-238.
22. Terra SG, McGorray SP, Wu R, McNamara DM, Cavallari LH, Walker JR et al. Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: A report from the NHLBI-sponsored WISE study. Int J Obes (Lond) 2005; 29: 746-754.
23. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL et al. Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001; 88: 1034-1037.
24. Holloway JW, Dunbar PR, Riley GA, Sawyer GM, Fitzharris PF, Pearce N et al. Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30: 1097-1103.